Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair. [PDF]
Castaño J +6 more
europepmc +1 more source
Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model. [PDF]
Radszuweit P +18 more
europepmc +1 more source
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis. [PDF]
Trentin L +12 more
europepmc +1 more source
Drug-tolerant persister cells: the deadly survivors in hematological malignancies. [PDF]
Ma Q, Cao T, Zhou L, Cheng J, Zhao L.
europepmc +1 more source
RBM15B recognizes H3K79me2 to guide selective m<sup>6</sup>A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemia. [PDF]
Chen TQ +13 more
europepmc +1 more source
Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.
Sanjuan-Pla A +6 more
europepmc +1 more source
KMT2A-rearranged leukemia: from mechanism to drug development. [PDF]
Ernst P, S Kyei P, Yokoyama A.
europepmc +1 more source
Mechanism of AF9 (MLLT3)-Partner Dissociation in Mixed-Lineage Leukemia-Rearranged Leukemia. [PDF]
Sharma S, Joshi K, Saha A.
europepmc +1 more source
IGF2BP3 redirects glycolytic flux to promote one-carbon metabolism and RNA methylation. [PDF]
Sharma G +21 more
europepmc +1 more source
Chemotherapy-free treatment of B-lymphoid/myeloid mixed phenotype acute leukemia: two case reports and literature review. [PDF]
Wang YF, Dai JY, Li MY, Jiang T.
europepmc +1 more source

